KARYOPHARM THERAP.DL-0001 earnings per share and revenue

25K earnings per share for the last quarter are -0.33 EUR whereas the estimation was -0.28 EUR which accounts for -16.13% surprise. รายได้ของบริษัทในช่วงเวลาเดียวกันมีจำนวน 30.58 M EUR แม้ว่าจะมีตัวเลขประมาณ 32.08 M EUR ก็ตาม Estimated earnings per share for the next quarter are -0.31 EUR, and revenue is expected to reach 31.96 M EUR. Also watch annual changes over time to get a bigger picture of 25K earnings per share and revenue dynamics.